FIG
WX

Fortress Investment Group’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Fortress Investment Group’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-221,200
Closed -$9.56M – 102
2015
Q3 		$9.56M Buy
+221,200
New +$9.33M 0.15% 24

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Fortress Investment Group's WX Position: Q4 2015 in Review

Fortress Investment Group sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 221,200 shares — an estimated $9.56M sold.

Fortress Investment Group first reported a position in WX in Q3 2015 and held it in 1 quarter. The position peaked at $9.56M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Fortress Investment Group reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Fortress Investment Group sold 221,200 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $9.56M.
  • Fortress Investment Group first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q3 2015 and held it in 1 quarter.
  • Fortress Investment Group's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $9.56M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Fortress Investment Group's 13F filing for Q4 2015, filed 16 Feb 2016.